[The role of hyperinsulinemia in the immunopathogenesis of atherosclerosis in diabetics]. 1991

E I Krasil'nikova, and I S Freĭdlin

In chronic insulin overdosage patients with insulin-dependent diabetes mellitus have marked shifts in the values of blood serum lipid spectrum, increased number of circulating immune complexes correlating with the increased amount of immunoreactive insulin, and considerable shifts of the functional and metabolic characteristics of blood monocytes. Chronic overdosage of insulin leads in these patients to stable shifts of biochemical and immunological values similar to those encountered in patients with ischemic heart disease but without diabetes. These shifts persist in stable normoglycemia and predispose to the development of atherosclerosis.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E I Krasil'nikova, and I S Freĭdlin
February 1988, Metabolism: clinical and experimental,
E I Krasil'nikova, and I S Freĭdlin
January 1994, Polski tygodnik lekarski (Warsaw, Poland : 1960),
E I Krasil'nikova, and I S Freĭdlin
March 2002, Circulation,
E I Krasil'nikova, and I S Freĭdlin
August 2004, Journal of leukocyte biology,
E I Krasil'nikova, and I S Freĭdlin
July 1996, Diabetes,
E I Krasil'nikova, and I S Freĭdlin
August 1995, Clinical and investigative medicine. Medecine clinique et experimentale,
E I Krasil'nikova, and I S Freĭdlin
May 2002, Deutsche medizinische Wochenschrift (1946),
E I Krasil'nikova, and I S Freĭdlin
October 2006, Medizinische Monatsschrift fur Pharmazeuten,
E I Krasil'nikova, and I S Freĭdlin
February 2002, Deutsche medizinische Wochenschrift (1946),
E I Krasil'nikova, and I S Freĭdlin
November 2004, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!